Form 4: Checkpoint Therapeutics CFO Sells Shares to Cover Tax Obligations

William Garrett Gray, CFO of Checkpoint Therapeutics, sold shares to cover tax obligations related to vesting restricted stock.

Summary

• On February 6, 2025, William Garrett Gray, the Chief Financial Officer of Checkpoint Therapeutics, Inc., sold 74,110 shares of common stock at a price of $3.67.
• The sale was executed to satisfy tax withholding obligations related to the vesting of 187,200 shares of restricted stock.
• Gray had no discretion over the sale, which was transacted automatically according to company policy.
• Following the transaction, Gray beneficially owns 1,458,644 shares of Checkpoint Therapeutics common stock, including restricted shares that vest over time.

Sentiment

Score: 5

Explanation: The document describes a routine transaction (sale of shares to cover tax obligations). It doesn't indicate positive or negative sentiment.

Industry Context

Sales of shares by company executives to cover tax obligations upon vesting of restricted stock are a common practice.

Stakeholder Impact

• The sale of shares by the CFO could have a minor impact on shareholders due to the increased supply of shares in the market, but the impact is likely to be minimal given the relatively small number of shares sold.

Key Dates

Keywords

Checkpoint Therapeutics, William Garrett Gray, CFO, Form 4, Share Sale, Tax Obligations, Restricted Stock, Beneficial Ownership